Zobrazeno 1 - 1
of 1
pro vyhledávání: '"544"'
Autor:
Richard A. Larson, Brian J. Druker, Francois Guilhot, Stephen G. O'Brien, Gilles J. Riviere, Tillmann Krahnke, Insa Gathmann, Yanfeng Wang, for the IRIS Study Group [, BACCARANI, MICHELE
Publikováno v:
Blood. 111(8)
Imatinib at 400 mg daily is standard treatment for chronic myeloid leukemia in chronic phase. We here describe the correlation of imatinib trough plasma concentrations (Cmins) with clinical responses, event-free survival (EFS), and adverse events (AE